(2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a],70003-55-3 Products Supply

Name: (2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]
CAS NO.: 70003-55-3
Synonyms:
AC1L4EHM;(2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] acetate; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] hexanoate; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate;70003-55-3;Androstan-3-one, 17-(acetyloxy)-2-methyl-, (2alpha,5alpha,17beta)-,mixt. with (2alpha,5alpha,17beta)-17-hydroxy-2-methylandrostan-3-one, (2alpha,5alpha,17beta)-2-methyl-17-((1-oxohexyl)oxy)androstan-3-one and (2alpha,5alpha,17beta)-2-methyl-17-(1-oxopropoxy)androstan-3-one
Molecular Structure:
Molecular Formula: C₉₁H₁₄₄O₁₁

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: (2R,5S,8R,9S,10S,13S,14S,17S)-; [(3S,5S,8R,9S,10S,13S,14S,16S,; 1/C15H13NO/c1-2-16-14-6-4-3-5-; 1/C11H14N2O6/c1-17-7(14)4-12-2; [(5S,8R,9S,10S,13S,14S,17S)-10; [(5S,8R,9S,10S,13S,14S,17S)-10; 1/C15H18O2/c1-11(16)6-7-12-4-3; 1/C14H19NO2/c1-3-12-10-17-9-8-; 1/C11H9N5O/c1-17-6-2-3-8-9(4-6; 1/C14H16O4/c1-5-10-12-9(14(15); 1/C12H10N4O3/c1-3-19-12(18)10-; 1/C15H22O2/c1-10(2)6-5-7-11(3); 1/C15H18N2O/c18-15-12-7-3-2-6-; (3Z,5S,8R,9S,10S,13S,14S,17S)-; 1/C12H11NO4/c1-6-10(15)7-3-4-1; 1/C15H22O3/c1-9-10(2)14-12(11(; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C15H18O3/c1-8-4-5-13(16)15(3; 1/C19H15ClN2O2S/c1-11-19(23)24; 1/C18H19NO4/c1-22-15-8-11-10(7; 1/C17H16N2O3/c1-9(20)12-8-14-1; 1/C14H9Br2O2P/c15-11-6-8-13(17; 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C14H15O3P/c15-18(16-11-13-7-; 10',13'-dimethyl-17'-(6-methyl; 1/C15H10O4/c16-11-7-3-1-5-9(11; 1/C15H16N2O3/c1-10-5-3-4-6-13(; 1/C15H20N2/c1-10(2)14-12(9-16); 1/C21H26N2O4/c1-3-14-8-9-19(25; 1/C18H18O6/c1-22-14-8-13(20)15;